As a new hospital pathogen with resistance to several groups of antibiotics, Acinetobacter baumannii has emerged. Despite its clinical importance, scientific evidence on the microbiological and pharmacological aspects of this organism has been minimal until recently. The availability of complete genome sequences, bacterial genome manipulation molecular tools, and animal infection models allowed the identification of factors that play a role in A. The persistence and infection of baumannii. This analysis summarises the data currently available on A’s processes of epidemiology, molecular and drug resistance. Baumannii and its pharmacotherapeutic and clinical consequences for healthcare.
Dr. A. Rammohan
The Institute of Liver Disease & Transplantation, Dr. Rela Institute & Medical Centre, Bharat Institute of Higher Education & Research, Chennai, India.
Dr. S. D. Cherukuri
Somerset NHS Foundation Trust, Taunton, UK.
View Book :- https://bp.bookpi.org/index.php/bpi/catalog/book/359